DE60329614D1 - Polymerzusammensetzung sowie diese enthaltende darreichungsformen - Google Patents
Polymerzusammensetzung sowie diese enthaltende darreichungsformenInfo
- Publication number
- DE60329614D1 DE60329614D1 DE60329614T DE60329614T DE60329614D1 DE 60329614 D1 DE60329614 D1 DE 60329614D1 DE 60329614 T DE60329614 T DE 60329614T DE 60329614 T DE60329614 T DE 60329614T DE 60329614 D1 DE60329614 D1 DE 60329614D1
- Authority
- DE
- Germany
- Prior art keywords
- polymeric composition
- pharmaceutical forms
- forms containing
- pharmaceutical
- polymeric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2002/031062 WO2003026626A2 (en) | 2001-09-28 | 2002-09-28 | Modified release dosage forms |
| PCT/US2002/031024 WO2003026625A1 (en) | 2001-09-28 | 2002-09-28 | Modified release dosage forms |
| PCT/US2002/031129 WO2003026630A1 (en) | 2001-09-28 | 2002-09-28 | Dosage forms having an inner core and outer shell with different shapes |
| PCT/US2002/031163 WO2003026627A1 (en) | 2001-09-28 | 2002-09-28 | Composite dosage forms |
| PCT/US2002/031117 WO2003026629A2 (en) | 2001-09-28 | 2002-09-28 | Modified release dosage forms |
| PCT/US2003/008960 WO2004028514A1 (en) | 2002-09-28 | 2003-03-21 | Polymer composition and dosage forms comprising the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60329614D1 true DE60329614D1 (de) | 2009-11-19 |
Family
ID=34271652
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60329614T Expired - Lifetime DE60329614D1 (de) | 2002-09-28 | 2003-03-21 | Polymerzusammensetzung sowie diese enthaltende darreichungsformen |
| DE60335270T Expired - Lifetime DE60335270D1 (de) | 2002-09-28 | 2003-03-21 | Darreichungsformen zur verzögerten freisetzung mit zwei kernen und einer öffnung |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60335270T Expired - Lifetime DE60335270D1 (de) | 2002-09-28 | 2003-03-21 | Darreichungsformen zur verzögerten freisetzung mit zwei kernen und einer öffnung |
Country Status (8)
| Country | Link |
|---|---|
| JP (3) | JP2006517182A (de) |
| CN (3) | CN1700907A (de) |
| AT (1) | ATE444739T1 (de) |
| AU (4) | AU2003220466A1 (de) |
| BR (5) | BR0314787A (de) |
| CA (3) | CA2500311A1 (de) |
| DE (2) | DE60329614D1 (de) |
| MX (1) | MXPA05003283A (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2470463C (en) | 2004-06-09 | 2012-09-18 | Lornamead Brands, Inc. | Tooth whitening products and methods of making the same |
| SA07280459B1 (ar) * | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني |
| WO2009153635A1 (en) * | 2008-06-19 | 2009-12-23 | University Of Witwatersrand, Johannesburg | A chronotherapeutic pharmaceutical dosage form |
| US20130011449A1 (en) * | 2010-03-23 | 2013-01-10 | Shiori Tomioka | Solid preparation |
| WO2013009701A2 (en) * | 2011-07-08 | 2013-01-17 | The University Of North Carolina At Chapel Hill | Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders |
| HK1203162A1 (en) * | 2012-02-07 | 2015-10-23 | 麦克内尔-Ppc股份有限公司 | Rapidly disintegrating coated tablets |
| WO2013183497A1 (ja) * | 2012-06-05 | 2013-12-12 | 武田薬品工業株式会社 | 有核錠 |
| AU2015317469B2 (en) * | 2014-09-19 | 2018-03-15 | The Procter & Gamble Company | Pulsed release phenylephrine dosage forms |
| KR102810926B1 (ko) | 2017-12-20 | 2025-05-22 | 퍼듀 퍼머 엘피 | 남용 억제 황산모르핀 제형 |
| MX2020006886A (es) * | 2017-12-29 | 2020-11-11 | Laxxon Medical Ag | Sistema para suministro de medicamento. |
| US12409163B2 (en) | 2021-07-30 | 2025-09-09 | Evecxia Therapeutics, Inc. | Method of enhancing 5-hydroxytryptophan (5-HTP) exposure |
| MX2024001390A (es) * | 2021-07-30 | 2024-05-17 | Evecxia Therapeutics Inc | Formas de dosificacion gastrorretentivas de 5-hidroxitriptofano. |
| CN115295864B (zh) * | 2021-11-09 | 2023-08-11 | 深圳市德方创域新能源科技有限公司 | 正极补锂添加剂及其制备方法与应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0662824A1 (de) * | 1992-09-30 | 1995-07-19 | Pfizer Inc. | Formkörper enthaltend einen kern und eine umhüllung mit nicht konstanter dicke |
| GB9402203D0 (en) * | 1994-02-04 | 1994-03-30 | Smithkline Beecham Plc | Pharmaceutical formulation |
| DE4431653C2 (de) * | 1994-09-06 | 2000-01-20 | Lohmann Therapie Syst Lts | Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung |
| IT1282576B1 (it) * | 1996-02-06 | 1998-03-31 | Jagotec Ag | Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili |
| US6602521B1 (en) * | 1998-09-29 | 2003-08-05 | Impax Pharmaceuticals, Inc. | Multiplex drug delivery system suitable for oral administration |
| EP1275373A4 (de) * | 2000-04-17 | 2007-04-04 | Astellas Pharma Inc | Arzneistoffabgabesystem zur vermeidung von pharmakokinetischen wechselwirkungen zwischen wirkstoffen und methode hierzu |
| PT1368006E (pt) * | 2001-02-13 | 2006-08-31 | Astrazeneca Ab | Nova formulacao de libertacao modificada |
-
2003
- 2003-03-21 CA CA002500311A patent/CA2500311A1/en not_active Abandoned
- 2003-03-21 CA CA002500312A patent/CA2500312A1/en not_active Abandoned
- 2003-03-21 DE DE60329614T patent/DE60329614D1/de not_active Expired - Lifetime
- 2003-03-21 CA CA2500313A patent/CA2500313C/en not_active Expired - Fee Related
- 2003-03-21 BR BR0314787-8A patent/BR0314787A/pt not_active IP Right Cessation
- 2003-03-21 JP JP2004539769A patent/JP2006517182A/ja active Pending
- 2003-03-21 AU AU2003220466A patent/AU2003220466A1/en not_active Abandoned
- 2003-03-21 AU AU2003218359A patent/AU2003218359A1/en not_active Abandoned
- 2003-03-21 CN CN03825324.0A patent/CN1700907A/zh active Pending
- 2003-03-21 JP JP2004539770A patent/JP2006517183A/ja active Pending
- 2003-03-21 CN CN03825331.3A patent/CN1700908A/zh active Pending
- 2003-03-21 AT AT03714356T patent/ATE444739T1/de not_active IP Right Cessation
- 2003-03-21 BR BR0314777-0A patent/BR0314777A/pt not_active Application Discontinuation
- 2003-03-21 BR BR0314804-1A patent/BR0314804A/pt not_active Application Discontinuation
- 2003-03-21 AU AU2003225944A patent/AU2003225944A1/en not_active Abandoned
- 2003-03-21 JP JP2004539767A patent/JP2006517514A/ja active Pending
- 2003-03-21 CN CN03823065.8A patent/CN1684671A/zh active Pending
- 2003-03-21 AU AU2003220472A patent/AU2003220472A1/en not_active Abandoned
- 2003-03-21 MX MXPA05003283A patent/MXPA05003283A/es unknown
- 2003-03-21 DE DE60335270T patent/DE60335270D1/de not_active Expired - Lifetime
- 2003-03-21 BR BR0314781-9A patent/BR0314781A/pt not_active Application Discontinuation
- 2003-03-21 BR BR0314547-6A patent/BR0314547A/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003218359A1 (en) | 2004-04-19 |
| CA2500312A1 (en) | 2004-04-08 |
| MXPA05003283A (es) | 2005-11-23 |
| CA2500313C (en) | 2011-06-07 |
| CN1700907A (zh) | 2005-11-23 |
| BR0314547A (pt) | 2005-08-09 |
| BR0314787A (pt) | 2005-07-26 |
| JP2006517183A (ja) | 2006-07-20 |
| AU2003225944A1 (en) | 2004-04-19 |
| JP2006517182A (ja) | 2006-07-20 |
| CA2500311A1 (en) | 2004-04-08 |
| JP2006517514A (ja) | 2006-07-27 |
| AU2003220466A1 (en) | 2004-04-19 |
| BR0314781A (pt) | 2005-07-26 |
| DE60335270D1 (de) | 2011-01-20 |
| ATE444739T1 (de) | 2009-10-15 |
| BR0314777A (pt) | 2005-07-26 |
| CN1700908A (zh) | 2005-11-23 |
| AU2003220472A1 (en) | 2004-04-19 |
| CN1684671A (zh) | 2005-10-19 |
| BR0314804A (pt) | 2005-08-02 |
| CA2500313A1 (en) | 2004-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI20011478L (fi) | Farmaseuttinen koostumus | |
| ATE401800T1 (de) | Hochintensive süssstoffzusammensetzung und deren abgabe | |
| DE60335282D1 (de) | Polycarbonatharzzusammensetzung und formkörper daraus | |
| DE60331324D1 (de) | Polycarbonatharzzusammensetzung und formkörper | |
| EP1298180A4 (de) | Hydrophobe und lipophobe zusammensetzung | |
| PT1501534E (pt) | Formulacoes farmaceuticas | |
| EP1513825A4 (de) | Antituberkulöses arzneimittel: zusammensetzungen und verfahren | |
| IL170758A0 (en) | 7-amino-isoindolyl compounds and their pharmaceutical uses | |
| DE60209252D1 (de) | Stabilisierte polymerzusammensetzung | |
| EP1425019A4 (de) | Pharmazeutische zusammensetzung | |
| PT1467724E (pt) | Composicao farmaceutica orodispersavel de agomelatina | |
| EP1512408A4 (de) | Antibakterielles mittel und antibakterielle zusammensetzung | |
| DE60334379D1 (de) | Copolymerverbindung, diese enthaltende polymerzusammensetzung, bilderzeugungsverfahren und dieselbe benutzende bilderzeugungsvorrichtung | |
| DE60312049D1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff | |
| DK1587478T3 (da) | Farmaceutisk sammensætning | |
| DE60329614D1 (de) | Polymerzusammensetzung sowie diese enthaltende darreichungsformen | |
| FI20022128A0 (fi) | Farmaseuttinen koostumus | |
| PL361518A1 (pl) | Zastosowanie substancji oraz kompozycja farmaceutyczna | |
| PT1558263E (pt) | Composicao farmaceutica de libertacao prolongada | |
| DE60217390D1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
| DE60322926D1 (de) | Photopolymerisierbare zusammensetzung und verwendung davon | |
| DK1474152T3 (da) | Orodispergerbar farmaceutisk sammensætning omfattende ivabradin | |
| DK1467750T3 (da) | Orodispergerbar farmaceutisk sammensætning omfattende perindopril | |
| DE60321641D1 (de) | Photopolymerisierbare Initiatorkombination und photopolymerisierbare Zusammensetzung | |
| DE60334283D1 (de) | Tintenzusammensetzung und tintenstrahlaufzeichnungsverfahren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |